SanBio Company Limited (OTCMKTS:SNBIF) Short Interest Update

SanBio Company Limited (OTCMKTS:SNBIF) saw a significant increase in short interest in October. As of October 31st, there was short interest totalling 851,500 shares, an increase of 65.3% from the October 15th total of 515,000 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

SanBio Price Performance

Shares of SNBIF stock remained flat at C$3.85 during midday trading on Wednesday. The firm’s 50-day simple moving average is C$3.85 and its 200 day simple moving average is C$3.85. SanBio has a 52 week low of C$3.80 and a 52 week high of C$4.25.

SanBio Company Profile

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson’s disease, spinal cord injury, and Alzheimer’s disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.